Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.5 USD | +0.80% | +6.71% | +17.97% |
07/05 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
07/05 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.97% | 5.49B | |
+5.28% | 109B | |
+11.27% | 105B | |
-0.38% | 22.25B | |
-12.08% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.36% | 16.85B | |
+2.87% | 13.76B | |
+35.80% | 12.46B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Sector Update: Health Care Stocks Drifting Away from Wednesday Session Highs